Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a 403 Forbidden error in place of the study details, replacing the trial content and navigation with a generic error message. This indicates that access to the record is blocked on this URL.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating a minor version update. This change does not alter the study content or user-facing information on the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new build. This change is metadata-level and does not alter the study details or other visible content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a backend update to the page. This signals an underlying update to the page template or documentation without altering visible content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page tooling or template, while the visible study information and structure remain the same.SummaryDifference0.1%

- Check90 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, signaling a newer page release. This change does not modify any study content, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.